Cetraria islandica
 
Scientific research
The global sale of plant-derived medical products is growing. People experience efficacy of herbal medicine in terms of prophylaxis, cure or relieve with non-serious diseases. Scientists are constantly looking for novel active compounds in plants to use in food, medicine and cosmetics.
For many years, scientists have showed considerable interest in finding the active components of Iceland Moss as well as examining the effect of these components on animals and human cells. Many scientific papers have been published on the matter.
 
Active compounds in Iceland Moss
The main active components in Iceland Moss are:
The Polysaccharides, Lichenin, Isolichenin and Galactomannan.
The Lichen acids, Protolichesterinic acid and Fumarprotocetraric acid that are secondary metabolites produced by the fungal part of the lichen. Lichen acids are only found in lichens.
 
Scientific research (in vitro) indicates that the active compounds in Iceland Moss can prevent the growth of bacteria, viruses and cancer cells, as well as stimulate the immune system.
Although clinical studies have not been done so far to confirm this activity in the human body, it is clear that the results give interesting outcome, that support the traditional believe that Iceland Moss is beneficial to maintain health and well being.
 
Research at the University of Iceland
(Í þessum kafla hefur orðin víxlun á setningum....röðin á að vera eins og hér)
For many years, scientific work on active components in lichens, have been performed at the Dept. of Pharmacy at the University of Iceland. The professors Kristín Ingólfsdóttir Ph.D. and Elín Soffía Ólafsdóttir, Ph.D. are leading this work in cooperation with scientists around the world. The result can be studied in numerous published articles.
 
Main research on Iceland Moss
Overview over the main research and results that have been performed in the latest years.
References and a short abstract are given below for the main research.